相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Mutated clones driving leukemic transformation are already detectable at the single-cell level in CD34-positive cells in the chronic phase of primary myelofibrosis
Sandra Parenti et al.
NPJ PRECISION ONCOLOGY (2021)
Pevonedistat targets malignant cells in myeloproliferative neoplasms in vitro and in vivo via NFκB pathway inhibition
Tim Kong et al.
Blood Advances (2021)
A Humanized Animal Model Predicts Clonal Evolution and Therapeutic Vulnerabilities in Myeloproliferative Neoplasms
Hamza Celik et al.
CANCER DISCOVERY (2021)
Inflammatory Pathophysiology as a Contributor to Myeloproliferative Neoplasms
Daniel Arthur Corpuz Fisher et al.
FRONTIERS IN IMMUNOLOGY (2021)
Leukemia secondary to myeloproliferative neoplasms
Andrew J. Dunbar et al.
BLOOD (2020)
Signalling input from divergent pathways subverts B cell transformation
Lai N. Chan et al.
NATURE (2020)
RSK inhibitor BI-D1870 inhibits acute myeloid leukemia cell proliferation by targeting mitotic exit
Hee-Don Chae et al.
Oncotarget (2020)
Splicing factor YBX1 mediates persistence of JAK2-mutated neoplasms
Ashok Kumar Jayavelu et al.
NATURE (2020)
Myeloid Kruppel-like factor 2 is a critical regulator of metabolic inflammation
David R. Sweet et al.
NATURE COMMUNICATIONS (2020)
Genomics of MPN progression
Anand A. Patel et al.
HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM (2020)
Targeting compensatory MEK/ERK activation increases JAK inhibitor efficacy in myeloproliferative neoplasms
Simona Stivala et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
Cytokine production in myelofibrosis exhibits differential responsiveness to JAK-STAT, MAP kinase, and NFκB signaling
Daniel A. C. Fisher et al.
LEUKEMIA (2019)
Genetic programming of macrophages generates an in vitro model for the human erythroid island niche
Martha Lopez-Yrigoyen et al.
NATURE COMMUNICATIONS (2019)
CSF1R inhibitors exhibit antitumor activity in acute myeloid leukemia by blocking paracrine signals from support cells
David K. Edwards et al.
BLOOD (2019)
Identification of functionally primitive and immunophenotypically distinct subpopulations in secondary acute myeloid leukemia by mass cytometry
Shovik Bandyopadhyay et al.
CYTOMETRY PART B-CLINICAL CYTOMETRY (2019)
Targeting FLT3 mutations in AML: review of current knowledge and evidence
Naval Daver et al.
LEUKEMIA (2019)
Analysis of Genetically Diverse Macrophages Reveals Local and Domain-wide Mechanisms that Control Transcription Factor Binding and Function
Verena M. Link et al.
CELL (2018)
Ruthenium counterstaining for imaging mass cytometry
Raul Catena et al.
JOURNAL OF PATHOLOGY (2018)
Dual-specificity phosphatase 6 (DUSP6): a review of its molecular characteristics and clinical relevance in cancer
Muhammad Khairi Ahmad et al.
CANCER BIOLOGY & MEDICINE (2018)
JARID2 Functions as a Tumor Suppressor in Myeloid Neoplasms by Repressing Self-Renewal in Hematopoietic Progenitor Cells
Hamza Celik et al.
CANCER CELL (2018)
Functional genomic landscape of acute myeloid leukaemia
Jeffrey W. Tyner et al.
NATURE (2018)
Mass cytometry analysis reveals hyperactive NF Kappa B signaling in myelofibrosis and secondary acute myeloid leukemia
D. A. C. Fisher et al.
LEUKEMIA (2017)
Genomics of Myeloproliferative Neoplasms
Katerina Zoi et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Computational correction of copy number effect improves specificity of CRISPR-Cas9 essentiality screens in cancer cells
Robin M. Meyers et al.
NATURE GENETICS (2017)
Targeting c-FOS and DUSP1 abrogates intrinsic resistance to tyrosine-kinase inhibitor therapy in BCR-ABL-induced leukemia
Meenu Kesarwani et al.
NATURE MEDICINE (2017)
Reversed graph embedding resolves complex single-cell trajectories
Xiaojie Qiu et al.
NATURE METHODS (2017)
Kruppel-like factors in mammalian stem cells and development
Agnieszka B. Bialkowska et al.
DEVELOPMENT (2017)
A Stringent Systems Approach Uncovers Gene-Specific Mechanisms Regulating Inflammation
Ann-Jay Tong et al.
CELL (2016)
Myeloproliferative neoplasms and inflammation: whether to target the malignant clone or the inflammatory process or both
S. Koschmieder et al.
LEUKEMIA (2016)
Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq
Itay Tirosh et al.
SCIENCE (2016)
A CRISPR Dropout Screen Identifies Genetic Vulnerabilities and Therapeutic Targets in Acute Myeloid Leukemia
Konstantinos Tzelepis et al.
CELL REPORTS (2016)
Tissue damage drives co-localization of NF-κB, Smad3, and Nrf2 to direct Rev-erb sensitive wound repair in mouse macrophages
Dawn Z. Eichenfield et al.
ELIFE (2016)
MPNs as Inflammatory Diseases: The Evidence, Consequences, and Perspectives
Hans Carl Hasselbalch et al.
MEDIATORS OF INFLAMMATION (2015)
Spatial reconstruction of single-cell gene expression data
Rahul Satija et al.
NATURE BIOTECHNOLOGY (2015)
limma powers differential expression analyses for RNA-sequencing and microarray studies
Matthew E. Ritchie et al.
NUCLEIC ACIDS RESEARCH (2015)
miRNA-mRNA integrative analysis in primary myelofibrosis CD34+ cells: role of miR-155/JARID2 axis in abnormal megakaryopoiesis
Ruggiero Norfo et al.
BLOOD (2014)
Circadian Enhancers Coordinate Multiple Phases of Rhythmic Gene Transcription In Vivo
Bin Fang et al.
CELL (2014)
Genomic and functional analysis of leukemic transformation of myeloproliferative neoplasms
Raajit Rampal et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Dynamic Reprogramming of Signaling Upon Met Inhibition Reveals a Mechanism of Drug Resistance in Gastric Cancer
Andrea Z. Lai et al.
SCIENCE SIGNALING (2014)
STAR: ultrafast universal RNA-seq aligner
Alexander Dobin et al.
BIOINFORMATICS (2013)
Mutations and prognosis in primary myelofibrosis
A. M. Vannucchi et al.
LEUKEMIA (2013)
Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia
Timothy J. Ley et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells
Wanjuan Yang et al.
NUCLEIC ACIDS RESEARCH (2013)
HES1 opposes a PTEN-dependent check on survival, differentiation, and proliferation of TCRβ-selected mouse thymocytes
Gladys W. Wong et al.
BLOOD (2012)
A Validated Regulatory Network for Th17 Cell Specification
Maria Ciofani et al.
CELL (2012)
Expression of protein-tyrosine phosphatases in Acute Myeloid Leukemia cells: FLT3 ITD sustains high levels of DUSP6 expression
Deepika Arora et al.
CELL COMMUNICATION AND SIGNALING (2012)
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
Jordi Barretina et al.
NATURE (2012)
A map of the cis-regulatory sequences in the mouse genome
Yin Shen et al.
NATURE (2012)
A Double-Blind, Placebo-Controlled Trial of Ruxolitinib for Myelofibrosis
Srdan Verstovsek et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
JAK Inhibition with Ruxolitinib versus Best Available Therapy for Myelofibrosis
Claire Harrison et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data
Ethan Cerami et al.
CANCER DISCOVERY (2012)
Kruppel-like factor 2 regulated gene expression in mouse embryonic yolk sac erythroid cells
Latasha C. Redmond et al.
BLOOD CELLS MOLECULES AND DISEASES (2011)
Gene expression profiling in the leukemic stem cell-enriched CD34+ fraction identifies target genes that predict prognosis in normal karyotype AML
H. J. M. de Jonge et al.
LEUKEMIA (2011)
Single-Cell Mass Cytometry of Differential Immune and Drug Responses Across a Human Hematopoietic Continuum
Sean C. Bendall et al.
SCIENCE (2011)
The dual-specificity MAP kinase phosphatases: critical roles in development and cancer
O. Bermudez et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2010)
edgeR: a Bioconductor package for differential expression analysis of digital gene expression data
Mark D. Robinson et al.
BIOINFORMATICS (2010)
Physiological Jak2V617F Expression Causes a Lethal Myeloproliferative Neoplasm with Differential Effects on Hematopoietic Stem and Progenitor Cells
Ann Mullally et al.
CANCER CELL (2010)
JAK2 V617F and beyond: role of genetics and aberrant signaling in the pathogenesis of myeloproliferative neoplasms
Stephen T. Oh et al.
EXPERT REVIEW OF HEMATOLOGY (2010)
GAGE: generally applicable gene set enrichment for pathway analysis
Weijun Luo et al.
BMC BIOINFORMATICS (2009)
Zebrafish chemical screening reveals an inhibitor of Dusp6 that expands cardiac cell lineages
Gabriela Molina et al.
NATURE CHEMICAL BIOLOGY (2009)
Dual-specificity MAP kinase phosphatases (MKPs) and cancer
Stephen M. Keyse
CANCER AND METASTASIS REVIEWS (2008)
AURKA is one of the downstream targets of MAPK1/ERK2 in pancreatic cancer
T. Furukawa et al.
ONCOGENE (2006)
MPLW515L is anovel somatic activating mutation in myelofibrosis with myeloid metaplasia
Yana Pikman et al.
PLOS MEDICINE (2006)
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
A Subramanian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Hes binding to STAT3 mediates crosstalk between Notch and JAK-STAT signalling
S Kamakura et al.
NATURE CELL BIOLOGY (2004)
Elevated expression of IL-3Rα in acute myelogenous leukemia is associated with enhanced blast proliferation, increased cellularity, and poor prognosis
U Testa et al.
BLOOD (2002)
FLT3 internal tandem duplication mutations associated with human acute myeloid leukemias induce myeloproliferative disease in a murine bone marrow transplant model
LM Kelly et al.
BLOOD (2002)
Medical progress: Myelofibrosis with myeloid metaplasia.
A Tefferi
NEW ENGLAND JOURNAL OF MEDICINE (2000)
分享论文
